Related Experiment Video
Updated: Jul 16, 2026

08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Macrocyclic lathyrane diterpenes as antitumor promoters
Rozália Pusztai1, Maria-José U Ferreira, Noélia Duarte
1Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
Anticancer Research
|March 14, 2007
Summary
Certain plant compounds can inhibit human cytomegalovirus (CMV) immediate-early (IE) antigen expression in lung cancer cells. This finding offers potential new strategies for preventing and treating cancers linked to CMV infection.
Area of Science:
- Oncology
- Virology
- Natural Product Chemistry
Background:
- Human cytomegalovirus (CMV) is frequently found in tumor tissues.
- Accumulated CMV immediate-early (IE) antigen is implicated in tumor promotion and progression.
- Inhibiting CMV IE antigen expression is a potential strategy for cancer prevention and treatment.
Purpose of the Study:
- To identify plant-derived compounds with antitumor-promoting properties.
- To investigate the effect of specific diterpenoids on CMV IE antigen expression in lung cancer cells.
Main Methods:
- Isolation of six macrocyclic lathyrane-type diterpenoids (latilagascenes A-E and jolkinol B) from Euphorbia lagascae.
- Treatment of CMV-infected A549 lung cancer cells with the isolated compounds.
- Assessment of the compounds' effect on CMV IE antigen expression.
Main Results:
- Five of the six tested compounds (latilagascenes A-C, E, and jolkinol B) significantly reduced CMV IE antigen expression.
- Latilagascene D did not show inhibitory effects on CMV IE antigen expression.
Conclusions:
- Macrocyclic lathyrane-type diterpenoids from Euphorbia lagascae demonstrate potential in inhibiting CMV IE antigen expression.
- These compounds represent promising candidates for further development as anti-CMV agents in cancer therapy.
Related Concept Videos
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
